Enveric Biosciences, Inc.
ENVB
$1.69
$0.095.63%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.25M | 1.78M | 1.43M | 1.22M | 1.36M |
| Depreciation & Amortization | 37.20K | 39.50K | 40.40K | 40.00K | 81.00K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.63M | 2.19M | 1.87M | 2.52M | 2.19M |
| Operating Income | -1.63M | -2.19M | -1.87M | -2.52M | -2.19M |
| Income Before Tax | -1.63M | -2.19M | -1.87M | -2.52M | -2.19M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.63M | -2.19M | -1.87M | -2.52M | -2.19M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.63M | -2.19M | -1.87M | -2.52M | -2.19M |
| EBIT | -1.63M | -2.19M | -1.87M | -2.52M | -2.19M |
| EBITDA | -1.60M | -2.15M | -1.83M | -2.48M | -2.11M |
| EPS Basic | -1.08 | -6.12 | -10.81 | -11.65 | -14.58 |
| Normalized Basic EPS | -0.68 | -2.08 | -3.74 | -7.28 | -9.12 |
| EPS Diluted | -1.08 | -6.12 | -10.81 | -11.65 | -14.58 |
| Normalized Diluted EPS | -0.68 | -2.08 | -3.74 | -7.28 | -9.12 |
| Average Basic Shares Outstanding | 1.51M | 659.70K | 313.20K | 216.30K | 149.80K |
| Average Diluted Shares Outstanding | 1.51M | 659.70K | 313.20K | 216.30K | 149.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |